Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Leogane, Haiti

被引:33
|
作者
Mathieu, E
Lammie, PJ
Radday, J
Beach, MJ
Streit, T
Wendt, J
Addiss, DG
机构
[1] Ctr Dis Control & Prevent, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA 30341 USA
[2] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA
[3] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA
来源
关键词
D O I
10.1179/000349804X3135
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In October 2000, to interrupt transmission of Wuchereria bancrofti, an intense health-education campaign followed by a mass drug administration (MDA) with diethylcarbamazine and albendazole was undertaken in Leogane, Haiti. Three months after the MDA, which was the first in the study area, a knowledge-attitude-practice (KAP) survey, with a cluster-sample design and probability sampling, was undertaken, to determine the existing knowledge of the local residents, their attitudes toward the MDA, and the possible reasons for non-compliance. Questionnaire-based interviews were used to explore the KAP of 304 subjects (one randomly chosen resident aged > 14 years from each selected household) in 33 communities. Most (93%) of the interviewees were aware of filariasis and 72% knew at least one clinical sign of the disease. Awareness of the MDA was high (91%). The most frequently mentioned sources of information were other people (56%) and radio announcements (33%). More than 80% of the respondents encouraged other people to take the drugs distributed in the MDA and 63% had been treated. The primary reasons given for failing to take the drugs were absenteeism during the distribution (17%), use of contraceptive drugs (12%) and pregnancy (11 %). In a multivariate analysis, being male [odds ratio (OR) =3.3; 95% confidence interval (CI)=1.5-7.4], knowing that a mosquito transmits the disease (OR=2.6; CI=1.2-5.4), and having learned about the MDA through posters and banners (OR= 2.9; CI =1.2-7.5) were found to be positively associated with taking the drugs. Information from such post-treatment surveys should be useful in developing better health communication for subsequent MDA.
引用
收藏
页码:703 / 714
页数:12
相关论文
共 50 条
  • [21] A campaign of 'communication for behavioural impact' to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage
    Ramaiah, KD
    Kumar, KNV
    Hosein, E
    Krishnamoorthy, P
    Augustin, DJ
    Snehalatha, KS
    Nanda, B
    Das, PK
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2006, 100 (04): : 345 - 361
  • [22] Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines
    Maria Lourdes E Amarillo
    Vicente Y Belizario
    Jewel T Sadiang-abay
    Stephanie Anne M Sison
    Ariane Marie S Dayag
    Parasites & Vectors, 1
  • [23] Simulating the effect of evaluation unit size on eligibility to stop mass drug administration for lymphatic filariasis in Haiti
    Kostandova, Natalya
    Desir, Luccene
    Direny, Abdel
    Knipes, Alaine
    Lemoine, Jean Frantz
    Fayette, Carl Renand
    Kirby, Amy
    Gass, Katherine
    PLOS NEGLECTED TROPICAL DISEASES, 2022, 16 (01):
  • [24] Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines
    Amarillo, Maria Lourdes E.
    Belizario, Vicente Y., Jr.
    Sadiang-abay, Jewel T.
    Sison, Stephanie Anne M.
    Dayag, Ariane Marie S.
    PARASITES & VECTORS, 2008, 1 (1)
  • [25] Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis
    Alshehri, Abdullah
    Chhonker, Yashpal S.
    Bala, Veenu
    Edi, Constant
    Bjerum, Catherine M.
    Koudou, Benjamin G.
    John, Lucy N.
    Mitja, Oriol
    Marks, Michael
    King, Christopher L.
    Murry, Daryl J.
    PLOS NEGLECTED TROPICAL DISEASES, 2023, 17 (06):
  • [26] ENDING MASS TREATMENT FOR LYMPHATIC FILARIASIS IN 87 HEALTH DISTRICTS IN CAMEROON
    Benjamin, Biholong
    Clarisse, Ebene
    Akame, Julie
    Mbia, Patrick
    Fokam, Carine
    Hendji, Michel
    Zhang, Yaobi
    Reid, Steven
    Nko'Ayissi, Georges
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 166 - 166
  • [27] Mass Drug Administration for the Elimination of Lymphatic Filariasis - Port-au-Prince, Haiti, 2011-2012
    Streit, Thomas
    Desir, Luccene
    Oscar, Roland
    Lemoine, Jean Frantz
    Purcell, Nora Colleen
    Keller, Angela
    Lammie, Patrick J.
    Deming, Michael
    De Rochars, Valery E. Madsen Beau
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2013, 62 (23): : 466 - 468
  • [28] Socioeconomic factors associated with compliance with mass drug administration for lymphatic filariasis elimination in Kenya: Descriptive study results
    Njomo, Doris W.
    Amuyunzu-Nyamongo, M.
    Mukoko, Dunstan A.
    Magambo, Japheth K.
    Njenga, Sammy M.
    ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2012, 5 (02) : 103 - 110
  • [29] SIMULATING THE EFFECT OF EVALUATION UNIT SIZE IN DETERMINING ELIGIBILITY TO STOP MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS IN HAITI
    Kostandova, Natalya
    Desir, Luccene
    Direny, Abdel
    Knipes, Alaine
    Lemoine, Jean Frantz
    Monestime, Franck
    Renand, Fayette Carl
    Deming, Michael S.
    Kirby, Amy
    Gass, Katherine
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 18 - 18
  • [30] REVAMPING THE STRATEGY FOR MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS IN URBAN METROPOLITAN AREAS OF PORT AU PRINCE, HAITI
    Javel, Alain
    Fayette, Carl
    Monestime, Franck
    Denis, Eurica
    Knowles, Ellen
    Craciunoiu, Sarah
    Bennett, Cudjoe
    Lemoine, Jean-Frantz
    Direny, Abdel
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 611 - 612